aTyr Pharma, Inc. Share Price

aTyr Pharma, Inc. Share Price

NASDAQ: ATYR | Small Cap
$4.84
-$0.45 (-8.51%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

aTyr Pharma, Inc. Stock Performance

Open
$5.38
Prev. Close
$5.29
Circuit Range
N/A
Day Range
$4.80 - $5.38
Year Range
$0.10 - $7.91
Volume
2,106
Average Traded
$4.96

aTyr Pharma, Inc. Share Price Today

As of 18 November 2026, aTyr Pharma, Inc.'s share price is $4.84. The stock opened at $5.38, compared to its previous close of $5.29. During today's trading session, aTyr Pharma, Inc.'s share price traded between $4.80 and $5.38, with an average price of $5.09. Over the past 52 weeks, the stock has recorded a high of $7.91 and a low of $0.10. In terms of performance, aTyr Pharma, Inc.'s share price has risen by 792.99% over the last six months and is up 520.51% on a year-on-year basis.

aTyr Pharma, Inc. Share Price Chart

Line chart of the aTyr Pharma, Inc. price trend over the selected period. The price fell overall, ranging from 4.63 to 5.38, ending at 4.84.
$4.80$5.38
L
Show Current Price
H

aTyr Pharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
$450.05M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-20.92
Revenue (TTM)
$190.00M
Return On Equity (TTM)
-156.92%
Profit Margin
-39010.53%
Debt to Equity
0.01
Quarterly Earnings Growth YoY
-30.80%

aTyr Pharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$13.96-$10.79-$10.31-$18.26
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A22.71%4.45%-77.11%

aTyr Pharma, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.24$0.19
Net Profit-$64.02-$74.12
Net Profit Margin-26675.00%-39010.53%
Income ChangeN/A-15.78%

About aTyr Pharma, Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

aTyr Pharma, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$5.63
$4.88
-2.59%
Oct 2026
$0.30
$5.01
+1,542.62%
Sep 2026
$0.49
$0.30
-45.24%
Aug 2026
$0.49
$0.56
+16.04%
Jul 2026
$0.60
$0.48
-20.53%
Jun 2026
$0.52
$0.60
+11.44%
May 2026
$0.83
$0.54
-32.75%
Apr 2026
$0.82
$0.81
+3.87%
Mar 2026
$0.94
$0.78
-18.83%
Feb 2026
$0.88
$0.96
+10.27%
Jan 2026
$0.76
$0.87
+11.58%
Dec 2025
$0.78
$0.78
-0.38%

ATYR Share Price FAQs